A newer study includes a no-exercise group

Chun and colleagues reported a 12-week study in 2026. Seventy-three healthy sedentary adults entered the research process, and 64 adults aged 45–65 completed the intervention and were analyzed. Participants first chose whether to enter an exercise-and-diet program or a no-exercise group. Within those categories, creatine or placebo assignment was randomized and blinded.

The authors reported improvements in lean tissue, strength and muscular endurance in the creatine group without the structured exercise-and-diet intervention, along with selected cognitive and biomarker findings. The experimental creatine amount was 10g daily. That number describes the research protocol; it is not a recommendation for readers to copy.

The paper adds evidence to a question that combined-training trials cannot answer directly. It does not establish that a supplement can reproduce every benefit of exercise, guarantee a response for an older individual or resolve use during illness, rehabilitation or treatment-related inactivity.

Exercise participation was chosen, not randomized

The distinction in assignment is central. Randomizing creatine versus placebo within an activity category helps compare the supplement under those conditions. Allowing participants to choose the activity category leaves open differences between the people who selected training and those who did not.

That means an apparent contrast between the exercise and no-exercise groups may reflect more than exercise alone. Motivation, preferences, baseline characteristics or adherence can differ even when investigators measure and adjust some variables. The design should not be described simply as four fully randomized groups without acknowledging this step.

The exercise program also included a diet intervention intended to promote weight loss. A finding from that combined package cannot isolate exercise, diet and supplementation as though each had been changed independently in every participant. For a shopper, this is a reminder to read the Methods section before accepting a causal claim from a chart.

The authors reported meaningful limitations

The 2026 analysis used the 64 completers, and its duration, population and measures limit generalization. The authors described individual cognitive and biomarker findings as exploratory, noting multiple outcomes without an across-outcome adjustment. Repeated cognitive testing can also create practice effects, even with familiarization procedures. The paper also notes that creatinine-based eGFR can be influenced by creatine intake and muscle mass; directly measured GFR and cystatin C were unavailable.

DXA measured lean tissue, which should not be translated automatically into an equal amount of newly built muscle protein. A body-composition category and a tissue-level mechanism are different things. Strength and endurance tests add useful information, but they still represent particular laboratory tasks rather than every activity of daily living.

Funding came from a WoodNext Foundation gift. AlzChem supplied supplements and funded homocysteine assays; the paper stated sponsors were not involved in data collection, analysis or interpretation. One author disclosed creatine-industry relationships and an AlzChem advisory role. These facts do not decide whether the results are correct, but they belong in an informed reading of the study.

An earlier trial gives another perspective

A 2014 trial by Gualano and colleagues assigned 60 vulnerable older women to placebo, creatine, placebo plus resistance training, or creatine plus resistance training for 24 weeks. This four-group design directly separated the interventions. The primary outcome concerned strength, with lean mass, bone measures and functional tests also assessed.

The combined creatine-and-training group had better bench-press improvement than the other groups and greater appendicular lean-mass gains. Its leg-press improvement exceeded the non-training groups but was not statistically different from training plus placebo. Fat mass and bone outcomes did not significantly differ between groups. We reviewed the primary abstract rather than completing a full funding appraisal for that older trial.

This pattern resists a simple slogan. Some combined-intervention outcomes were better; others did not show an added creatine effect. The result does not mean training and a supplement are interchangeable, nor does it mean every possible outcome requires exactly the same combination.

Different populations can produce different answers

Healthy adults aged 45–65, vulnerable older women, trained athletes and people recovering from surgery are not the same study population. Eligibility criteria affect who can safely participate and which question the experiment is designed to answer. A positive result in one group cannot supply automatic clearance for another.

The NIH exercise fact sheet places creatine research in the context of specific performance tasks and variable responses. Its discussion of repeated high-intensity work is useful background, but it should not be stretched into proof about all non-exercising adults. Our ingredient introduction covers that wider context.

If inactivity reflects pain, an injury, a medical condition or a recent procedure, the underlying reason matters. A clinician or rehabilitation professional can assess suitable activity and nutrition goals. Buying a powder should not delay that evaluation or create a reason to disregard restrictions on movement.

Decide what outcome you actually mean

“Does it work?” can mean a change in scale weight, a stronger grip, easier stair climbing, improved memory or a different blood result. Those are separate outcomes. Before interpreting a trial, identify the one you care about and check whether the researchers measured it directly.

Even a relevant average result does not show that every participant improved. Small groups can also produce imprecise estimates, and an encouraging short-term outcome may not persist. Look for the comparison, uncertainty and follow-up rather than relying only on whether one number rose from baseline.

The diabetes research chapter illustrates the same issue with blood sugar: a measured marker under a particular exercise program cannot become a general treatment promise. The HCl comparison shows why the actual comparison groups also determine which product claims a paper can support.

Keep product decisions on their own evidence

A trial cannot authenticate the tub in a shopping cart. Product identity, ingredient amount, warnings and testing records still need review. Our six-product comparison and batch-trail exercise help with that documentary work, while retaining the site's commercial disclosure.

For someone considering creatine without a training program, the research is more nuanced than either “useless unless you lift” or “a replacement for exercise.” There are relevant findings worth discussing, including newer evidence, but important limits remain. Choose the clinical question first, assess the matching study carefully, and bring personal suitability decisions to a healthcare professional who knows the reason for your current activity level.